AI-Powered Chatbot Integrated With Wearable-Derived Data for Promoting Mental Health Among Finnish Higher Education Students
Mental health problems among adolescents and young adults have increased globally, underscoring the urgent need for accessible, preventive, and systemic approaches to promoting student mental health. This pilot study aims to evaluate the feasibility, conversational quality, and preliminary effectiveness of an AI-powered chatbot integrated with wearable-derived physiological data intervention to provide personalized and timely mental health support for Finnish higher education students. The study explores how real-time stress indicators, such as heart rate variability (HRV), can inform the chatbot's adaptive and proactive interactions to promote students' mental health in daily life.
The study setting will be the Faculty of Medicine, University of Turku in Finland. A total of 15-20 participants will be recruited with convenience sampling for this study. The inclusion criteria for participants are: 1) enrolled students at the Faculty of Medicine, 2) voluntary and consenting, 3) Finnish-speaking, 4) having a smart phone (Android/iOS), and 5) having none to mild levels of psychological distress. Participants who self-report a diagnosis of mental health disorder, or having an acute treatment for mental health will be excluded.
The intervention in this study consists of 4-week daily use of a AI-powered chatbot. In addition to access to the chatbot, a wearable device will be given to each participant to collect physiological data related to their stress (HRV), physical activity and sleep. At the end of week 2 and 3 of the study, participants will receive a personalized report summarizing the data collected by the device. Throughout the intervention period, the research assistant will contact participants once a week to ensure their well-being. At the end of the study, an interview will be arranged with each participant.
The study data includes the conversations with the chatbot, physiological data from the wearable device, daily stress questions, background information questionnaire, Depression Anxiety Stress Scale (DASS-21) (at the beginning of the intervention and at weeks 2 and 4), Chatbot Usability Questionnaire (CUQ) (at weeks 2 and 4) and an end-of-study semi-structured interview.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Anna Axelin
- Telefonnummer: +358405029905
- E-mail: anmaax@utu.fi
Studiesteder
-
-
-
Turku, Finland
- Rekruttering
- University of Turku
-
Kontakt:
- Anna Axelin
- Telefonnummer: +358405029905
- E-mail: anmaax@utu.fi
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Study population consists of higher education students.
Beskrivelse
Inclusion Criteria:
- enrolled students at the Faculty of Medicine (bachelor's, master's, or doctoral level students)
- voluntary and consenting
- Finnish-speaking (native speaker or enrolled in a Finnish study program)
- having a smart phone (Android/iOS)
- having none to mild levels of psychological distress
Exclusion Criteria:
- self-reported diagnosis of mental health disorder, or having an acute treatment for mental health
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Higher education students
|
Daily use of an AI-powered chatbot and a wearable device to collect physiological data related to stress, physical activity and sleep. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Eligibility of participants
Tidsramme: 4 weeks
|
The number of individuals screened, the proportion that meets the inclusion criteria, and the main reasons for exclusion will be documented to assess the appropriateness and practicality of the eligibility criteria. |
4 weeks
|
|
Recruitment and retention of participants
Tidsramme: 4 weeks
|
The number of participants enrolled, the proportion completing the whole intervention as well as assessments, and attrition rates will be recorded to evaluate recruitment efficiency and participant retention. |
4 weeks
|
|
Engagement of the participants
Tidsramme: 4 weeks
|
Quantitative indicators that include the frequency of chatbot interactions, average session length, and response rates will be analyzed to assess adherence to study procedures and sustained engagement over time. |
4 weeks
|
|
Technical performance of the chatbot
Tidsramme: 4 weeks
|
System reliability will be examined through logs of technical errors, data integration issues, and chatbot downtime events, providing insights into the stability and operational consistency of the intervention platform. |
4 weeks
|
|
Safety of the chatbot
Tidsramme: 4 weeks
|
It will be assessed whether the chatbot's interactions are free from harm and whether it can appropriately identify and manage high-risk user input. Evaluation focuses on the chatbot's ability to detect and respond to indications of severe distress or crisis, such as expressions of self-harm, suicidal ideation, abuse, or other high-risk situations. Following the MHealth-EVAL framework (Chen et al., 2024), responses will be annotated using a binary scale, where "0" indicates the presence of harmful or unsafe content or failure to address crisis cues appropriately, and "1" indicates a safe and supportive response. |
4 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Psychological distress
Tidsramme: 4 weeks
|
Psychological distress will be assessed using the Depression Anxiety Stress Scales-21 (DASS-21), which is a 21-item self-report instrument measuring three dimensions of negative emotional states: depression, anxiety, and general stress. Each subscale includes seven items rated on a 4-point Likert scale (0-3), with higher scores indicating greater symptom severity. DASS-21 will be administered before, at two weeks, and after the intervention to assess potential changes in participants' psychological stress. |
4 weeks
|
|
Behavioral change and health literacy
Tidsramme: 4 weeks
|
At the end of the 4-week intervention, semi-structured interviews will be conducted with each participant individually to gain an in-depth understanding of their experiences with the chatbot as well as any behavioral changes they perceived during the study. In addition, the participants' understanding of AI health literacy will be discussed. |
4 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- TY/2154/2025
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Dataset may be made available for secondary use through the international open science repository Dryad. Identifiers will be removed from the dataset to ensure that individual participants cannot be identified. Secondary use of the data requires a permission process that adheres to established research ethics principles.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .